PRGS&Tech is South Korea’s only team left in XPRIZE Healthspan’s $110 million race to prove a drug can help everyone age more ...

Six proteomic clocks detect a younger biological age signal in an IPF trial – but separating geroprotection from treatment ...

South Korean RNA-editing firm enters Eli Lilly’s San Diego innovation hub to speed its precision gene-therapy pipeline toward ...

Deal with Singapore’s MuseCell Innovations could bring $300 million in business and 200 jobs to Celularity’s cell platform.

Licensing deal brings Amprion’s misfolded-protein test closer to European trial sites, aiming to speed up neurodegenerative ...

A newly allowed US patent covers the lipid delivery system behind Daewoong’s experimental mRNA platform for reprogramming ...

Fresh off the world’s largest mammalian longevity screen, Longevica names ex-Genentech exec Prasun Mishra to steer science ...

A new 10–15 minute series aims to bring clarity and nuance to the big and bold ideas shaping the future of human longevity.

Alzheimer’s trial needing 760. For a biotech betting everything on one pill, that’s the good kind of surprise.

Function Health now lets members feed lab results into ChatGPT, Claude and Perplexity, turning AI answers into ones grounded ...

USPTO grant strengthens Alterity’s IP position and opens a path for ATH434 into Parkinson’s disease investment.